our Premium Content: News alerts, weekly reports and conference planners
DRUG:
vadacabtagene leraleucel (JCAR015)
i
Other names: JCAR015, anti-CD19-CD28-zeta modified CAR CD3+ T lymphocyte therapy, 19-28z T cells, Autologous T cells genetically targeted to the B cell specific antigen CD19
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
P1, N=23, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Trial completion date: May 2024 --> May 2025 | Trial primary completion date: May 2024 --> May 2025
5 months ago
Trial completion date • Trial primary completion date
P1, N=93, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Trial completion date: Jan 2024 --> Jan 2025 | Trial primary completion date: Jan 2024 --> Jan 2025
9 months ago
Trial completion date • Trial primary completion date
P1/2, N=50, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Trial completion date: Dec 2023 --> Dec 2026 | Trial primary completion date: Dec 2023 --> Dec 2026
over 1 year ago
Trial completion date • Trial primary completion date
P1, N=93, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Trial completion date: Jan 2023 --> Jan 2024 | Trial primary completion date: Jan 2023 --> Jan 2024
almost 2 years ago
Trial completion date • Trial primary completion date
P1, N=23, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Trial completion date: May 2023 --> May 2024 | Trial primary completion date: May 2023 --> May 2024
almost 2 years ago
Trial completion date • Trial primary completion date
P1/2, N=50, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Trial completion date: Dec 2022 --> Dec 2023 | Trial primary completion date: Dec 2022 --> Dec 2023
almost 2 years ago
Trial completion date • Trial primary completion date
P1, N=93, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Trial completion date: Jan 2022 --> Jan 2023 | Trial primary completion date: Jan 2022 --> Jan 2023
almost 3 years ago
Trial completion date • Trial primary completion date
P1, N=23, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Trial completion date: May 2022 --> May 2023 | Trial primary completion date: May 2022 --> May 2023
almost 3 years ago
Trial completion date • Trial primary completion date
P1/2, N=50, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Trial completion date: Dec 2021 --> Dec 2022 | Trial primary completion date: Dec 2021 --> Dec 2022
almost 3 years ago
Trial completion date • Trial primary completion date
P1, N=23, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Trial completion date: May 2021 --> May 2022 | Trial primary completion date: May 2021 --> May 2022
over 3 years ago
Clinical • Trial completion date • Trial primary completion date
P1, N=93, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Trial completion date: Jan 2021 --> Jan 2022 | Trial primary completion date: Jan 2021 --> Jan 2022
almost 4 years ago
Trial completion date • Trial primary completion date
P1, N=23, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Trial completion date: May 2020 --> May 2021 | Trial primary completion date: May 2020 --> May 2021
over 4 years ago
Clinical • Trial completion date • Trial primary completion date